Explore
Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026
Nuvectis Pharma Reports Increased Net Loss in Q1 2026
Read More
Trendline
Curis to Announce Q1 2026 Financial Results and Host Webcast
Curis to Announce Q1 2026 Financial Results and Host Webcast
Read More
Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Read More
Trendline
IDEAYA Biosciences Reports Positive Results and Business Updates for Q1 2026
IDEAYA Biosciences Reports Positive Results and Business Updates for Q1 2026
Read More
Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Expansion Plans
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Expansion Plans
Read More
Trendline
SOPHiA GENETICS Reports Strong Q1 2026 Growth Driven by AI-Powered Precision Medicine
SOPHiA GENETICS Reports Strong Q1 2026 Growth Driven by AI-Powered Precision Medicine
Read More
Trendline
GO Residential REIT Reports Strong Q1 2026 Results, Exceeding Forecasts
GO Residential REIT Reports Strong Q1 2026 Results, Exceeding Forecasts
Read More
Trendline
Exelixis Reports Q1 2026 Financial Results and Announces New Stock Repurchase Program
Exelixis Reports Q1 2026 Financial Results and Announces New Stock Repurchase Program
Read More
Trendline
Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results
Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results
Read More
Trendline
ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates
ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates
Read More
Trendline
Pulmonx Corp Reports Decline in Q1 2026 Revenue Amid China Shipment Delays
Pulmonx Corp Reports Decline in Q1 2026 Revenue Amid China Shipment Delays
Read More
Trendline
Mirum Pharmaceuticals Achieves Key Milestone in PSC Treatment with Volixibat
Mirum Pharmaceuticals Achieves Key Milestone in PSC Treatment with Volixibat
Read More
